Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. IGEA Pharma N.V.
  6. News
  7. Summary
    IGPH   NL0012768675

IGEA PHARMA N.V.

(IGPH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

IGEA Pharma N : H1 Loss Narrows on Gains From Financial Liabilities, Sale of Assets

10/01/2021 | 12:19am EST


ę MT Newswires 2021
All news about IGEA PHARMA N.V.
11/25IGEA PHARMA N : GBC Research report IGEA Pharma N.V.
PU
11/25IGEA PHARMA N : GBC AG Publishes initial equity research report with buy recommendation an..
PU
11/25IGEA PHARMA N.V. : Gbc ag publishes initial equity research report with buy recommendation..
EQ
10/04IGEA PHARMA N : GBC AG to start equity coverage of IGEA Pharma
PU
10/01IGEA PHARMA N : H1 Loss Narrows on Gains From Financial Liabilities, Sale of Assets
MT
09/30IGEA Pharma N.V. Reports Earnings Results for First Half 2021
CI
09/30Igea Pharma N.V. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
09/30IGEA PHARMA N : discloses its half-2021 financials
PU
09/27IGEA PHARMA N : has been granted the listing of the new shares from SIX Exchange Regulatio..
PU
09/08IGEA PHARMA N : to submit the listing prospectus to the SIX following the business combina..
PU
More news
Financials
Sales 2021 0,14 M 0,16 M 0,16 M
Net income 2021 - - -
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Capitalization 99,9 M 113 M 113 M
Capi. / Sales 2021 714x
Capi. / Sales 2022 1,96x
Nbr of Employees 2
Free-Float 82,3%
Chart IGEA PHARMA N.V.
Duration : Period :
IGEA Pharma N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 0,30 €
Average target price 1,05 €
Spread / Average Target 252%
Managers and Directors
Vicenzo Moccia Chairman-Management Board
Sector and Competitors
1st jan.Capi. (M$)
IGEA PHARMA N.V.-42.59%113
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.67.89%23 009
BIOMÉRIEUX1.73%15 682
10X GENOMICS, INC.1.90%15 407
DIASORIN S.P.A.3.88%10 914
NATERA, INC.-10.47%8 188